Advertisement
U.S. markets closed

Aelis Farma SA (AELIS.PA)

Paris - Paris Delayed Price. Currency in EUR
2.7000-0.2000 (-6.90%)
At close: 05:35PM CET
Currency in EUR

Valuation Measures4

Market Cap (intraday) 39.49M
Enterprise Value 31.99M
Trailing P/E 43.79
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)5.07
Price/Book (mrq)3.97
Enterprise Value/Revenue 4.24
Enterprise Value/EBITDA 37.90

Trading Information

Stock Price History

Beta (5Y Monthly) 0.21
52-Week Change 3-78.36%
S&P500 52-Week Change 331.33%
52 Week High 313.6000
52 Week Low 32.5800
50-Day Moving Average 33.6956
200-Day Moving Average 310.0220

Share Statistics

Avg Vol (3 month) 3993
Avg Vol (10 day) 32.28k
Shares Outstanding 513.62M
Implied Shares Outstanding 613.71M
Float 83.05M
% Held by Insiders 10.00%
% Held by Institutions 10.98%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Jun 30, 2024

Profitability

Profit Margin -65.19%
Operating Margin (ttm)-88.89%

Management Effectiveness

Return on Assets (ttm)-17.67%
Return on Equity (ttm)-51.97%

Income Statement

Revenue (ttm)10.78M
Revenue Per Share (ttm)0.82
Quarterly Revenue Growth (yoy)-27.70%
Gross Profit (ttm)N/A
EBITDA -7.55M
Net Income Avi to Common (ttm)-7.03M
Diluted EPS (ttm)-0.5300
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)12.59M
Total Cash Per Share (mrq)0.92
Total Debt (mrq)5.08M
Total Debt/Equity (mrq)51.13%
Current Ratio (mrq)2.97
Book Value Per Share (mrq)0.75

Cash Flow Statement

Operating Cash Flow (ttm)-13.1M
Levered Free Cash Flow (ttm)-10.75M